vimarsana.com

Page 72 - பல்கலைக்கழகம் ஆஃப் டெக்சாஸ் ம்ட் ஆண்டர்சன் புற்றுநோய் மையம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

She can still save someone s life : Blood drive in Olympia Fields honors Kristin Oliver, who died last year at 31

She can still save someone s life : Blood drive in Olympia Fields honors Kristin Oliver, who died last year at 31
chicagotribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chicagotribune.com Daily Mail and Mail on Sunday newspapers.

A collaborative effort to evaluate treatment of liver and pancreatic tumors

A collaborative effort to evaluate treatment of liver and pancreatic tumors HOUSTON, DENVER and CHICAGO ? The University of Texas MD Anderson Cancer Center and TriSalus Life Sciences today announced a strategic research collaboration to evaluate the treatment of tumors of the pancreas and liver by integrating interventional delivery of SD-101, an investigational toll-like receptor 9 (TLR9) agonist, in combination with checkpoint inhibition immunotherapy. Under the agreement, MD Anderson and TriSalus will collaborate on studies evaluating the administration of investigational SD-101 intravascularly via TriSalus Food and Drug Administration (FDA) cleared, proprietary Pressure-Enabled Drug Delivery™ (PEDD™) technology across a range of liver and pancreatic solid tumors.

MD Anderson researchers recognized by AACR

“Scientists and clinicians in the early phases of their career are crucial to our mission to end cancer and play a central role in driving innovation in all areas of cancer research, prevention, diagnosis and treatment,” said Giulio Draetta, M.D., Ph.D., chief scientific officer at MD Anderson. “We congratulate these junior investigators on receiving such notable recognition from AACR for their high-impact work.” Navin: Outstanding Achievement in Basic Cancer Research This prestigious AACR scientific achievement award was established to recognize an early career investigator for achievements in basic cancer research. Navin was selected for his seminal contributions to the understanding of genome evolution and intratumor heterogeneity in breast cancer and for his invention of single-cell DNA sequencing, which has impacted many diverse fields of biology and biomedicine and has directly contributed to the establishment of the single cell genomics field.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.